On October 10, Litai Zhi Pharmaceutical announced that it had completed a seed round of financing of nearly 50 million yuan. This round of financing was jointly invested by iFLYX Ventures, L2F Light Source Entrepreneurs Fund and well-known industry parties. Light Source Capital acted as the exclusive financial advisor. This round of funding will mainly be used for core pipeline research and development, computing power investment, patent layout, talent recruitment and daily operation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.